Evaluation of ureterorenoscopic stone therapy - results with regard to complications, quality of life and stone-free rate
Completed
- Conditions
- N20Calculus of kidney and ureter
- Registration Number
- DRKS00007668
- Lead Sponsor
- Ruppiner Kliniken GmbH / Medizinische Hochschule Theodor Fontane
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 309
Inclusion Criteria
Consent-capable patient who undergoes a ureterorenoscopic stone therapy
Exclusion Criteria
Incapacitated patients
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life and complications after ureterorenoscopic stone therapy (URS). <br>Assessing Quality of Life with the Health Survey SF-8-Questionnaire and IPSS 30 days postoperatively. Detection of complications after Clavien-Dindo (grade 0-5) perioperatively and 30 days postoperatively.
- Secondary Outcome Measures
Name Time Method Reintervention after URS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying ureterorenoscopic stone therapy for kidney and ureter calculi in DRKS00007668?
How does ureterorenoscopic stone therapy compare to shock wave lithotripsy in terms of stone-free rates and complication profiles?
Are there specific biomarkers that predict successful stone-free outcomes following ureterorenoscopic interventions in DRKS00007668?
What are the most common adverse events associated with ureterorenoscopic stone therapy and how are they managed in clinical practice?
What combination therapies or alternative approaches are being explored alongside ureterorenoscopic treatment for kidney and ureter stones in observational studies?